Advances in Study on Mesenchymal Stem Cells in Treatment of Inflammatory Bowel Disease / 胃肠病学
Chinese Journal of Gastroenterology
;
(12): 101-104, 2018.
Artigo
em Chinês
| WPRIM
| ID: wpr-698151
ABSTRACT
Inflammatory bowel disease(IBD)is a non-specific,chronic intestinal inflammatory disease,and the pathogenesis of IBD is not completely clear. Mesenchymal stem cell(MSC)is a kind of pluripotent stem cell,which has the function of homing,tissue repair and immunomodulation. The therapeutic effects of MSC in systemic lupus erythematosus,graft-versus-host disease,myocardial infarction and some other diseases have been confirmed. Recent studies have shown that MSC has a unique advantage in the treatment of IBD. This article reviewed the advances in study on MSC in the treatment of IBD.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Gastroenterology
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS